Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Evaluation of Eslicarbazepine Acetate on Cardiac Repolarization in a Thorough QT/QTc Study
Publication

Evaluation of Eslicarbazepine Acetate on Cardiac Repolarization in a Thorough QT/QTc Study

Title
Evaluation of Eslicarbazepine Acetate on Cardiac Repolarization in a Thorough QT/QTc Study
Type
Article in International Scientific Journal
Year
2012
Authors
Vaz Da Silva, M
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Nunes, T
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Almeida, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gutierrez, MJ
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Litwin, JS
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
soares-da-silva, p
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 52
Pages: 222-233
ISSN: 0091-2700
Publisher: Wiley-Blackwell
Other information
Authenticus ID: P-002-DKF
Abstract (EN): This study investigated the effect of eslicarbazepine acetate (ESL) on cardiac repolarization in healthy adult volunteers. A randomized, placebo/active-controlled, 4-period crossover study was conducted in 67 participants. In 3 periods, participants received once-daily doses of ESL 1200 mg, ESL 2400 mg, and placebo for 5 days; in 1 period, participants received placebo on days 1 to 4 and a 400-mg moxifloxacin single dose on day 5. In each period, 24-hour 12-lead Halter monitoring was performed on days 1 (baseline) and 5. There was no clinically relevant effect of ESL 1200 mg and 2400 mg versus placebo on cardiac depolarization or repolarization as measured by the QRS or QTc intervals, respectively. Mean PR interval increased following ESL 1200 mg and 2400 mg, but there was no participant with a PR interval above the upper limit of the normal range (200 ms). The upper bound of the 95% confidence interval for the placebo-corrected change from baseline of the individually corrected QT interval (QTcI) following administration of ESL 1200 mg and ESL 2400 mg was <10 ms at every time point. Moxifloxacin caused an increase in QTcI above the 10-ms threshold for clinical significance at several time points, demonstrating assay sensitivity. It is concluded that administration of ESL 1200 mg and ESL 2400 mg did not induce a clinically significant prolongation of the QTcI interval.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 12
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID-19: Challenges in Pharmacoepidemiologic Research (2023)
Another Publication in an International Scientific Journal
da Silva, RF; Silva, AM; Morato, M; Ribeiro-Vaz, I; Polonia, J
Single-Dose Tolerability, Pharmacokinetics, and Pharmacodynamics of Etamicastat (BIA 5-453), a New Dopamine beta-Hydroxylase Inhibitor, in Healthy Subjects (2012)
Article in International Scientific Journal
Rocha, JF; Vaz Da Silva, M; Nunes, T; Igreja, B; Loureiro, AI; Bonifocio, MJ; Wright, LC; Falcao, A; Almeida, L; soares-da-silva, p
Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects (2005)
Article in International Scientific Journal
Luis Almeida; Patrício Soares da Silva; Amílcar Falcão; Joana Maia; Dago Mazur; Manfrend Gellert
Population Pharmacokinetic-Pharmacodynamic Modeling for Propofol Anesthesia Guided by the Bispectral Index (BIS) (2019)
Article in International Scientific Journal
Araújo, AM; Machado, H; de Pinho, PG; Soares da Silva, P; Falcão, A
Pharmacokinetics of Trans-resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects (2009)
Article in International Scientific Journal
Nunes, T; Almeida, L; Rocha, JF; Falcao, A; Fernandes Lopes, C; Loureiro, AI; Wright, L; Vaz Da Silva, M; soares-da-silva, p
Recommend this page Top
Copyright 1996-2024 © Reitoria da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2024-09-07 13:16:17 | Acceptable Use Policy | Data Protection Policy | Complaint Portal